Literature DB >> 17954373

Integrins: molecular determinants of glioma invasion.

Giovanna M D'Abaco1, Andrew H Kaye.   

Abstract

Gliomas, the most common form of brain tumour are characterised by a capacity to invade throughout normal brain tissue. This infiltrative nature is the hallmark of poor prognosis. A greater understanding of the molecular determinants that drive invasion may lead to improved therapy. Integrins are a large family of cell surface receptors that mediate interaction between a cell and the extracellular matrix. Integrins facilitate extracellular matrix dependent organization of the cytoskeleton and activation of intracellular signalling that is required for the regulation of cell adhesion and migration. Since integrins are key regulators of these processes, the role these receptors play in tumour invasion is a field of intense research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17954373     DOI: 10.1016/j.jocn.2007.06.019

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  43 in total

Review 1.  Molecularly targeted therapies for malignant gliomas.

Authors:  Andreas A Argyriou; Haralabos P Kalofonos
Journal:  Mol Med       Date:  2009 Mar-Apr       Impact factor: 6.354

2.  Cilengitide induces autophagy-mediated cell death in glioma cells.

Authors:  Stephanie L Lomonaco; Susan Finniss; Cunli Xiang; Hae Kyung Lee; Wei Jiang; Nancy Lemke; Sandra A Rempel; Tom Mikkelsen; Chaya Brodie
Journal:  Neuro Oncol       Date:  2011-07-25       Impact factor: 12.300

3.  Physical and functional interactions between a glioma cation channel and integrin-β1 require α-actinin.

Authors:  Arun K Rooj; Zhiyong Liu; Carmel M McNicholas; Catherine M Fuller
Journal:  Am J Physiol Cell Physiol       Date:  2015-06-24       Impact factor: 4.249

4.  A role for fibrillar collagen deposition and the collagen internalization receptor endo180 in glioma invasion.

Authors:  Ivo J Huijbers; Marjan Iravani; Sergey Popov; David Robertson; Safa Al-Sarraj; Chris Jones; Clare M Isacke
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

5.  Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma.

Authors:  Ruman Rahman; Stuart Smith; Cheryl Rahman; Richard Grundy
Journal:  J Oncol       Date:  2010-04-11       Impact factor: 4.375

6.  Modulation of cell adhesion and migration by the histone methyltransferase subunit mDpy-30 and its interacting proteins.

Authors:  Bin Xia; Alexandra Joubert; Benjamin Groves; Kevin Vo; Davin Ashraf; Derek Djavaherian; Jason Awe; Ying Xiong; Jacqueline Cherfils; Dzwokai Ma
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

7.  Snail plays an oncogenic role in glioblastoma by promoting epithelial mesenchymal transition.

Authors:  Jae Kyung Myung; Seung Ah Choi; Seung-Ki Kim; Kyu-Chang Wang; Sung-Hye Park
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

8.  Common variation in genes related to innate immunity and risk of adult glioma.

Authors:  Preetha Rajaraman; Alina V Brenner; Mary Ann Butler; Sophia S Wang; Ruth M Pfeiffer; Avima M Ruder; Martha S Linet; Meredith Yeager; Zhaoming Wang; Nick Orr; Howard A Fine; Deukwoo Kwon; Gilles Thomas; Nathaniel Rothman; Peter D Inskip; Stephen J Chanock
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

9.  Galectin-1 is implicated in the protein kinase C epsilon/vimentin-controlled trafficking of integrin-beta1 in glioblastoma cells.

Authors:  Shannon Fortin; Marie Le Mercier; Isabelle Camby; Sabine Spiegl-Kreinecker; Walter Berger; Florence Lefranc; Robert Kiss
Journal:  Brain Pathol       Date:  2009-10-08       Impact factor: 6.508

Review 10.  Galectins and gliomas.

Authors:  Marie Le Mercier; Shannon Fortin; Véronique Mathieu; Robert Kiss; Florence Lefranc
Journal:  Brain Pathol       Date:  2009-04-07       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.